Target
Complement factor D
Ligand
BDBM355681
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
32.0±n/a nM
Citation
 Altmann, EHommel, ULorthiois, ELMaibaum, JKOstermann, NQuancard, JRandl, SARogel, OVulpetti, A Complement pathway modulators and uses thereof US Patent  US9815819 Publication Date 11/14/2017 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM355681
Synonyms:
(1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1R,2R)-2-fluoro-2- phenyl-cyclopropyl)-amide | US9815819, 46
Type:
Small organic molecule
Emp. Form.:
C25H24FN5O3
Mol. Mass.:
461.4882
SMILES:
CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2cnccc12 |r|
Structure:
Search PDB for entries with ligand similarity: